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Abstract
AIM: To investigate local corticosterone production 
and angiotensin-Ⅰ converting enzyme (ACE) protein 
expression and their interaction in healthy and inflamed 
intestine.
METHODS: Acute intestinal inflammation was induced 
to six weeks old male Balb/c mice by administration 
of either 3% or 5% dextran sodium sulfate (DSS) in 
drinking water for 7 d (n  = 12 in each group). Healthy 
controls (n  = 12) were given tap water. Corticosterone 
production and ACE protein shedding were measured 
from ex vivo  incubates of the small and large intestine 
using EIA and ELISA, respectively. Morphological 
changes of the intestinal wall were assessed in 
hematoxylin-eosin stained tissue preparations of 
jejunum and distal colon. Effects of angiotensin Ⅱ, 
captopril and metyrapone on corticosterone production 
was assessed by incubating pieces of small intestine 
of healthy mice in the presence of 0.1, 1 or 10 µmol/L 
angiotensin Ⅱ, 1, 10 or 100 µmol/L captopril or 1, 10 
or 100 µmol/L metyrapone solutions and measuring 
corticosterone released to the incubation buffer after 
90 min (n  = 5 in each group).
Basic Study
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RESULTS: Both concentrations of DSS induced 
inflammation and morphological changes in large 
intestines but not in small intestines. Changes were 
observed as distortions of the crypt structure, mucosal 
erosion, immune cell infiltration to the mucosa and 
submucosal edema. Ex vivo  corticosterone production 
(2.9 ± 1.0 ng/mL vs  2.0 ± 0.8 ng/mL, P  = 0.034) and 
ACE shedding (269.2 ± 97.1 ng/mL vs  175.7 ± 52.2 ng/
mL, P  = 0.016) were increased in small intestines in 3% 
DSS group compared to the controls. In large intestine, 
corticosterone production was increased compared to 
the controls in both 3% DSS (229 ± 81 pg/mL vs  158 
± 30 pg/mL, P  = 0.017) and 5% DSS groups (366 
± 163 pg/mL vs  158 ± 30 pg/mL, P  = 0.002). Large 
intestine ACE shedding was increased in 5% DSS group 
(41.5 ± 9.0 ng/mL vs  20.9 ± 5.2 ng/mL, P  = 0.034). 
Angiotensin Ⅱ treatment augmented corticosterone 
production in small intestine at concentration of 10 
µmol/L (0.97 ± 0.21 ng/mg protein vs  0.40 ± 0.09 ng/
mg protein, P  = 0.036).
CONCLUSION: Intestinal ACE shedding is increased by 
DSS-induced intestinal inflammation and parallels local 
corticosterone production. ACE product angiotensin Ⅱ 
stimulates corticosterone formation in healthy intestine.
Key words: Dextran sodium sulfate; Inflammation; 
Angiotensin-I converting enzyme; Local corticosterone; 
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Core tip: Soluble and tissue levels of angiotensin-
Ⅰ converting enzyme (ACE) along with corticosterone 
production were examined in a dextran sulfate mouse 
model of intestinal inflammation. Intestine is a site of 
ACE shedding, which is increased by inflammation. 
ACE and corticosterone are increased in intestinal 
incubations of morphologically disrupted and intact 
parts of the intestine. ACE product Ang Ⅱ stimulates 
corticosterone production in small intestine. The results 
suggest that intestinal Renin-Angiotensin system and 
glucocorticoids might be counter-regulatory systems in 
regulation of inflammatory processes in the intestine. 
Salmenkari H, Issakainen T, Vapaatalo H, Korpela R. Local 
corticosterone production and angiotensin-Ⅰ converting enzyme 
shedding in a mouse model of intestinal inflammation. World J 
Gastroenterol 2015; 21(35): 10072-10079  Available from: URL: 
http://www.wjgnet.com/1007-9327/full/v21/i35/10072.htm  DOI: 
http://dx.doi.org/10.3748/wjg.v21.i35.10072
INTRODUCTION
Renin-angiotensin system (RAS) is best known as 
a regulator of systemic blood pressure. In addition, 
classic and alternative RAS regulate inflammatory 
processes in the vasculature[1]. Several components 
of RAS have been localized in various parts of 
the gastrointestinal tract but their function is not 
completely clear[2]. Angiotensin converting enzymes 
(ACE, ACE2) have been found throughout the human 
intestine[3-5]. The two types of angiotensin receptors 
(AT1R, AT2R) have also been detected in rat and 
human intestine suggesting that ACE aminopeptidases 
are not only food metabolizing enzymes but also have 
regulatory functions[2,4-7].
Another recent observation is the formation of 
adrenocortical glucocorticoid (GC) hormone, cor-
ticosterone, in the gut, where the regulation of 
synthesis is different than in adrenals[8-10]. Intestinal 
epithelium produces corticosterone to regulate 
inflammation by the action of tumor necrosis factor 
(TNF)-α[11]. In kidney and heart, angiotensin Ⅱ (Ang 
Ⅱ) induces TNF-α production[12,13]. Therefore, we 
hypothesized that these two systems, pro-inflam-
matory RAS and anti-inflammatory GCs, could play a 
counter-regulatory role in inflammatory processes of 
the intestine.
ACE is the central enzyme of classic RAS. ACE is an 
aminopeptidase, which cleaves two or three C-terminal 
amino acids from several peptides. The most 
important substrate for ACE is angiotensin Ⅰ (Ang Ⅰ) 
which is cleaved into pro-inflammatory Ang Ⅱ. ACE 
is a membrane-bound enzyme with a short cytosolic 
C-terminal tail[14]. The extracellular part consists 
of N-terminal and C-terminal domains which both 
possess a catalytic site[15]. ACE extracellular domains 
can be cleaved and released to the circulation by one 
or more so called ACE sheddase enzymes[15-17]. One 
of those enzymes is a metalloprotease ADAM9[18]. An 
analogous shedding mechanism by ADAM17 has been 
described for ACE2[19,20]. The role of ACE shedding 
is unclear but it is thought that ACE shedding might 
be a way to regulate local ACE activity or substrate 
specificity[15]. Furthermore, ACE shedding has been 
reported in lung during ischemia/reperfusion and in 
pulmonary endothelial cells in septic conditions and 
during LPS treatment in vitro[18,21,22]. Here, we report of 
ACE shedding outside vasculature from the intestinal 
tissue in response to DSS-induced inflammation.
Dextran sulfate (DSS)-model of colitis induces 
inflammation, mucosal erosion and bleeding in 
mouse colon. There have been several reports of 
DSS inducing mild inflammatory changes in small 
intestine histology and biochemical markers up to 
jejunum[23-25].
The aim of the study was to investigate intes-
tinal corticosterone production and ACE protein 
expression and their interaction in healthy and 
inflamed intestine.
MATERIALS AND METHODS
The study was conducted in the Institute of Bio-
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medicine, Pharmacology, at the University of 
Helsinki. The study was approved by National Animal 
Experimentation Committee of Finland according to 
EC Directive 86/609/ECC and Finnish Experimental 
Animal Act 62/2006.
Animals and colitis model
Six weeks old male balb/c mice weighing 20 g ± 
1 g were acclimatized to 12 h light-dark cycle and 
given water and standard rodent food, 2018 Teklad 
Global 18% Protein Rodent Diet (Harlan Laboratories, 
Indianapolis, IN, United States) ad libitum. Three 
or five percent (w/v) DSS was introduced in the 
drinking water for 7 d to induce acute colitis (n = 12 
in each group). Control group was given tap water. 
The animals were weighed daily and the weight was 
calculated in relation to that at the beginning of the 
experiment. Eight weeks old untreated balb/c male 
mice were used in ex vivo stimulation experiments.
Sample collection
After 7 d the mice were sacrificed by decapitation. 
Small and large intestines were excised, opened 
longitudinally and rinsed with Phosphate Buffered 
Saline (PBS) (137 mmol/L NaCl, 7.9 mmol/L Na2HPO4, 
2.7 mmol/L KCl, 1.5 mmol/L KH2PO4, pH = 7.4). Pieces 
of jejunum and distal colon were cut out, rinsed in 
Krebs buffer (119 mmol/L NaCl, 25 mmol/L NaHCO3, 
15 mmol/L KCl, 11 mmol/L Glucose, 1.6 mmol/L CaCl2, 
1.2 mmol/L KH2PO4, 1.2 mmol/L MgSO4) and fixed 
in 10% neutral-buffered formalin (Sigma Aldrich, St. 
Louis, MO, United States) for 24 h. The fixed tissues 
were washed with PBS and stored in 70% ethanol at 
+4 ℃ until paraffin embedding.
Ex vivo tissue incubation
The remaining part from duodenum to mid-jejunum 
and middle part of colon were sliced and incubated 
in pre-oxygenated Krebs buffer at 37 ℃ in gentle 
agitation. Samples of the buffer were taken after 90 
min of incubation and centrifuged at 13000 g. The 
supernatant was used for the experiments.
In another experiment, the whole small intestine of 
balb/c mice were cut into pieces which were randomly 
distributed and incubated in Krebs’ buffer, 0.1, 1 
or 10 µmol/L Ang Ⅱ (Sigma Aldrich) to stimulate 
corticosterone production, 1, 10 or 100 µmol/L cap-
topril (Sigma Aldrich) to block ACE activity or 1, 10 
or 100 µmol/L metyrapone (Sigma Aldrich) to inhibit 
corticosterone synthesis for 90 min. The supernatants 
were taken for corticosterone assay and the tissue 
pieces saved for total protein measurement.
Histological analyses 
Formalin-fixed paraffin embedded tissues were sliced 
and stained with hematoxylin and eosin stain. Crypt 
and villus structure, erosion of mucous membrane, 
inflammatory cells and submucosal edema were 
visually evaluated and compared between treatments.
Immunochemical assays 
Corticosterone was measured from ex vivo -incubate 
samples taken at 90 min of 8 small intestine and 
large intestine samples using a corticosterone EIA kit 
(Cayman Chemical, Michigan, MI, United States). ACE 
protein was measured from ex vivo -incubates and 
tissue lysates using ELISA (R&D System, Minnesota, 
MO, United States).
Statistical analysis
Comparisons of corticosterone formation and ACE 
shedding to controls and the expression analyses 
were done with Student’s unpaired t-test. Data is 
presented as mean ± SD in bar graphs. Correlations 
are presented with Pearson’s correlation coefficient 
and calculated with GraphPad Prism 5. P values less 
than 0.05 were considered statistically significant. 
Statistical analyses were evaluated by a statistics 
expert. The statistical methods of this study were 
reviewed by Dr. Oleg Kambur from the University of 
Helsinki.
RESULTS
Weight development 
The weight of the animals, given as percent of the 
mean initial weight (100%) was similar in all groups 
from day 1 to day 5, after which the animals in the 5% 
DSS group begun to lose weight. After 7 d, the animals 
in 5% DSS group weighed less than controls (93.1% 
± 0.8% vs 103.9% ± 0.5%, P < 0.001) or those in 
3% DSS group (93.1% ± 0.8% vs 100.5% ± 0.8%, P 
< 0.001). Animals treated with 3% DSS weighed less 
compared to controls after 7 d (100.5% vs 103.9%, 
P = 0.002). The weight loss was accompanied by 
diarrhea, with blood visible in the 5% DSS group.
Histological analyses
In the large intestine preparations, marked disruption 
of crypt structure, mononuclear cell infiltration, sub-
mucosal edema and mucosal erosion were observed in 
both 3% and 5% DSS groups but were not present in 
the control group (Figure 1). Histological changes were 
similar in both colitis groups. No pathological changes 
were observed in the small intestines in any group.
Corticosterone production
Corticosterone production in the ex vivo incubation 
of the small intestine samples was increased in 3% 
DSS group compared to control group at 90 min 
(2.9 ± 1.0 ng/mL vs 2.0 ± 0.8 ng/mL, P = 0.034) 
(Figure 2A). However, corticosterone levels did not 
differ significantly from control in 5% DSS-treated 
mice’s small intestines (2.5 ± 0.9 ng/mL vs 2.0 ± 1.0 
ng/mL, P = 0.16). In large intestine, DSS treatment 
stimulated corticosterone production in both 3% DSS 
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compared to control (41.5 ± 23.8 ng/mL vs 20.9 ± 
13.7 ng/mL, P = 0.034) but not in 3% DSS group. In 
tissue lysates, ACE protein concentrations were similar 
in all groups (Figure 2E and F).
Corticosterone and ACE correlations
Corticosterone and ACE concentrations correlated 
with each other in both small intestine (Pearson 
correlation 0.435, 95%CI: 0.169-0.642, P = 0.001) 
and large intestine (Pearson correlation 0.315, 95%CI 
0.033-0.550, P = 0.015) (Figure 3). Similarly, there 
was a correlation between small and large intestine 
corticosterone production (Pearson correlation, 0.534, 
0.295 to 0.711, P < 0.001) but not in ACE shedding 
(Pearson correlation 0.027, P = 0.429).
(0.23 ± 0.3 ng/mL vs 0.16 ± 0.1 ng/mL, P = 0.017) 
and 5% DSS groups (0.37 ± 0.5 ng/mL vs 0.16 ± 
0.1 ng/mL, P = 0.002) (Figure 2B). Corticosterone 
concentration in the incubates of 5% DSS-group’s 
large intestine samples was higher than in those of 3% 
DSS group (P = 0.026). 
ACE shedding
ACE protein was present in the supernatants of mouse 
ex vivo intestinal incubations (Figure 2C and D). 
ACE concentration was increased in 3% DSS group 
small intestine supernatants at 90 min compared 
to control (269.2 ± 90.9 ng/mL vs 175.7 ± 48.8 
ng/mL, P = 0.016). In large intestine incubates, ACE 
concentrations were increased in 5% DSS group 
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Figure 1  Small and large intestine histology. Hematoxylin eosin-stained tissue preparations of Control (A), 3% DSS (C) and 5% DSS (E) small intestines and 
Control (B), 3% DSS (D) and 5% DSS (F) large intestines. In D and F, crypt structure is damaged and mucosa is partly eroded. Edema is present in submucosa. 
Immune cells are present in mucosa and submucosa. Magnification × 20. DSS: Dextran sodium sulfate.
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Effects of angiotensin Ⅱ, captopril and metyrapone on 
corticosterone production in healthy tissue
Angiotensin Ⅱ, a stimulator of adrenal corti-
costerone synthesis, also increased corticosterone 
production in small intestines at 10 µmol/L con-
centration (0.97 ± 0.04 ng/mg protein vs 0.40 ± 
0.02 ng/mg protein, P = 0.036), which was the 
highest concentration tested (Figure 4A). Captopril, 
an inhibitor of ACE, had no effect on corticosterone 
production (Figure 4B). Metyrapone, an inhibitor 
of corticosterone synthesis, unexpectedly in-
creased corticosterone production at the smallest 
concentration tested, 1 µmol/L (0.95 ± 0.41 ng/mg 
protein vs 0.40 ± 0.02 ng/mg protein, P = 0.040), 
but had no effect at higher concentrations (Figure 
4C).
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Figure 2  Corticosterone production and angiotensin-Ⅰ converting enzyme shedding measured from healthy (control) and inflamed (DSS 3% or 5% 
induced in drinking fluid for 7 d) intestine samples (n = 8) after 90 min at 37  ℃. All the conditions were pretested in pilot experiments. Corticosterone production 
measured from the incubate buffer small intestine (A), large intestine (B). ACE shedding into incubate small intestine (C), large intestine (D). Tissue bound ACE from 
tissue lysate small intestine (E), large intestine (F). Data expressed as mean ± SD, n = 8 in each column. aP < 0.05 vs control. ACE: Angiotensin-I converting enzyme; 
DSS: Dextran sodium sulfate.
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DISCUSSION
Inflammatory bowel diseases (IBDs) are severe 
clinical ailments which manifest by diarrhea, intestinal 
bleeding and inflammation. Two major forms of IBD are 
ulcerative colitis (UC) and Crohn’s disease (CD). In UC, 
the inflammation is restricted to the colonic mucosa, 
whereas in CD the inflammation can sporadically affect 
any part of the intestinal tract and reach through all 
tissue layers. The causes of IBD are not fully understood 
but they are thought to be multifactorial and involve 
hereditary, immunological and environmental factors.
DSS is widely used to induce inflammation of 
the large intestine as an animal model of IBD[26]. 
However, it has been reported to induce inflammation 
in the small intestine as well, mainly in the ileum. In 
the present study, DSS treatment caused extensive 
histological damage in the mucosal layer of mouse 
colon but did not cause any clear histological damage 
in the jejunum. No appreciable changes were observed 
in muscularis mucosae, bearing more resemblance to 
ulcerative colitis than Crohn’s disease.
In the present study, we tested, as far as we know, 
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Figure 3  Correlation of angiotensin-Ⅰ converting enzyme protein and 
corticosterone in ex vivo intestinal incubations. A: Small intestine, n = 23; B: 
Large intestine, n = 24.
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Figure 4  Concentration-response effects of three different concentrations 
of angiotensin (A), captopril (B) and metyrapone (C) on corticosterone 
production measured from incubation buffer of small intestine sample 
after 90 min at 37  ℃. Individual values, mean ± SD from (n = 5 in each 
concentration) are given. aP < 0.05 vs control.
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for the first time the possible association between 
glucocorticoids and renin-angiotensin system in the 
gastrointestinal tract. These two systems interact in 
the adrenal cortex. 
Here, we report of inflammation-induced ACE 
protein shedding from mouse intestine in an ex vivo 
incubation. ACE shedding from vascular endothelium 
has been demonstrated earlier by others[15]. Previously, 
ACE activity has been measured from feces and 
considered as a sign of cell damage[27]. The current 
study did not assess whether ACE shedding occurs 
from the epithelial cells, immune cells or the vascular 
endothelium. However, due to the handling of the 
samples and recent reports of an ACE sheddase[18], 
it is likely the measured protein is in soluble form 
rather than membrane-bound. Furthermore, in severe 
colitis, we have observed angiotensinogen expression 
coinciding with ACE shedding (unpublished data).
Intestinal corticosterone production is increased 
by inflammation[8]. In line with previous studies, corti-
costerone production was increased in large intestines 
of DSS-treated mice. Furthermore, despite no his-
tological changes were observed in small intestines of 
DSS-treated mice, corticosterone production and ACE 
shedding were increased in jejuna of DSS-treated 
mice without marked differences in the tissue ACE 
levels. This might be due to milder, non-detectable, 
inflammation of the small intestine.
Since both of these processes, corticosterone 
production and ACE shedding, were increased by 
inflammation, we hypothesized that they might interact 
in the intestine. Indeed, corticosterone production was 
increased in small intestine tissue incubation by Ang Ⅱ. 
However, inhibition of ACE by captopril in vitro did not 
affect the basal corticosterone production. Further studies 
will show, whether captopril treatment in vivo has an 
effect on corticosterone production in inflamed intestine. 
Interestingly, the in vivo glucocorticoid synthesis inhibitor 
metyrapone did not inhibit corticosterone synthesis in 
this in vitro experimental setup but rather increased it at 
low concentration.
The present study shows that the DSS colitis 
model can be used to study local angiotensin system 
in intestinal inflammation. As conclusion, we demons-
trate ACE shedding from mouse intestine induced 
by inflammation. Pro-inflammatory ACE and anti-
inflammatory glucocorticoids appeared in incubation 
buffer even in the small intestine, far from the site 
of structural damage, further supporting reports of 
small intestinal manifestations of the DSS model. The 
results of this study suggest that intestinal RAS and 
glucocorticoids might be counter-regulatory systems in 
regulation of inflammatory processes in the intestine.
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Background
Inflammatory bowel diseases (IBD) such as Crohn´s disease and ulcerative 
colitis are increasing in Western societies. Different animal models (e.g., 
dextran sulfate sodium, TNBS) have been used to clarify their pathophysiology 
and pharmacological possibilities for the treatment. Recently, two important 
regulatory systems (renin-angiotensin-aldosterone and glucocorticoids), 
generally acting systemically have been described to exist also locally 
throughout the whole intestine. Because glucocorticoids are one of the main 
treatments of these inflammatory diseases, the local production may be of 
importance. Overexpression of renin- angiotensin system in vasculature is 
regarded pro-inflammatory. Therefore we decided to clarify in the mouse 
dextran sodium sulfate (DSS)-model, whether these two systems are 
associated in intestinal inflammation.
Research frontiers
Only few research groups have been interested in local expression and 
activities of these systems, and if so, only in one of these two items. Therefore 
the authors believe that the results will have some priority in this field and will 
stimulate activities of other research teams.
Innovations and breakthroughs
DSS model is rather traditional in pharmacology to study anti-inflammatory 
agents. The novelties are confirmation of the expression of the two inflammatory 
players in the intestinal epithelium ex vivo, and observation of association 
between them. There are differences between the small and large intestine. 
Furthermore glucocorticoid synthesis in the gut is differently regulated than in 
the adrenals. The strengths of the study are the diversity of the methods used. 
The present findings have also given us new ideas for the ongoing studies.
Applications
If intestinal epithelium in chronic inflammation is deficient to produce protective 
glucocorticoids and shows increased synthesis of pro-inflammatory components 
of renin-angiotensin system (RAS), the present findings are in agreement with 
the present clinical practice of use of local glucocorticoids in irritable bowel 
syndrome (IBS). Whether it would be found a direct mean to stimulate intestinal 
corticoid synthesis, it would offer a treatment without glucocorticoids' systemic 
adverse effects. Over-activity of RAS in intestinal inflammation would suggest 
treatment options for IBS with angiotensin converting enzyme (ACE) inhibitors 
or angiotensin type 1 receptor blockers.
Terminology
DSS-induced colitis is a model of inflammatory bowel diseases. DSS directly 
damages intestinal, specifically colonic, mucosa. ACE shedding refers to the 
enzymatic cleavage of the extracellular domains of ACE protein in which the 
active enzyme becomes soluble.
Peer-review
Salmenkari et al address the role of corticosterone production and ACE function 
in modulating intestinal inflammation, using a mouse DSS model of chemically 
induced IBD. They show that corticosterone and ACE are produced in this 
model, which could be of interest in vivo.
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